A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)
Titel:
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)
Auteur:
Hernández-Bernal, Francisco Ricardo-Cobas, Maria C. Martín-Bauta, Yenima Rodríguez-Martínez, Ernesto Urrutia-Pérez, Klaudia Urrutia-Pérez, Karen Quintana-Guerra, Joel Navarro-Rodríguez, Zadis Piñera-Martínez, Marjoris Rodríguez-Reinoso, José L. Chávez-Chong, Cristina O. Baladrón-Castrillo, Idania Melo-Suárez, Grettel Batista-Izquierdo, Alejandro Pupo-Micó, Alexis Mora-Betancourt, Ricardo Bizet-Almeida, Jacqueline Martínez-Rodríguez, Maria C. Lobaina-Lambert, Leonardo Velázquez-Pérez, Vivian M. Soler-Díaz, Jalimy Laurencio-Vallina, Sandra Meriño-Hechavarría, Tamara Carmenaty-Campos, Norberto Rodríguez-Montero, Enri Limonta-Fernández, Miladys Alonso-Valdés, Marel Hernández-Rodríguez, Reinier Pimentel-Vázquez, Eulogio Catasús-Álvarez, Karem M. Cabrera-Núñez, Maria V. Ayala-Ávila, Marta Muzio-González, Verena L.